An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
NCT ID: NCT00492479
Last Updated: 2007-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
INTERVENTIONAL
2007-06-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinerase Pro+Therapy Line day repair, serum, night repair
Kinerase Pro+Therapy Line Ultra rich day repair
LubriDerm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Likely to complete all study visits and follow study protocol
Exclusion Criteria
* Known hypersensitivity to any study product or their components
* Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
* Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
* Planned facial procedures during the study (microdermabrasion, facials, etc)
o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
* Recent (within 60 days) or concurrent participation in another clinical trial
* Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
* Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
* Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
* Wearing of cosmetics during study visits
35 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Medical
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Yoelin, MD
Role: PRINCIPAL_INVESTIGATOR
Private Practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Steve Yoelin MD practice
Santa Ana, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5314
Identifier Type: -
Identifier Source: org_study_id